Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05691192
What this trial is testing

Cognitive Reserve-building Activities in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Rigshospitalet, Denmark 60
Early research (Phase 1)Study completedNCT02293967
What this trial is testing

Mass Balance Study of MT-1303

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Tanabe Pharma Corporation 8
Not applicableStudy completedNCT00704834
What this trial is testing

Gene Expression Profiles in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of California, Davis 46
Testing effectiveness (Phase 2)Study completedNCT00203099
What this trial is testing

Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine

Who this might be right for
Relapse Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 18
Very early researchLooking for participantsNCT06629428
What this trial is testing

Effects of Ublituximab on Motor Functions in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Georgia State University 25
Not applicableStudy completedNCT02598167
What this trial is testing

Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Hoffmann-La Roche 223
Not applicableStudy completedNCT05366036
What this trial is testing

Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Eisai Korea Inc. 172
Not applicableLooking for participantsNCT06715436
What this trial is testing

Multiple Sclerosis and the Effects of Ketogenic Diet Therapy

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
IRCCS National Neurological Institute "C. Mondino" Foundation 111
Testing effectiveness (Phase 2)UnknownNCT00298662
What this trial is testing

Combination Therapy of Betaseron-Prograf in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais 30
Post-approval studies (Phase 4)UnknownNCT05340985
What this trial is testing

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingAdult ALLVitamin D3 Deficiency
Tehran University of Medical Sciences 54
Post-approval studies (Phase 4)Looking for participantsNCT07225361
What this trial is testing

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting
Northwestern University 40
Early research (Phase 1)Study completedNCT01097668
What this trial is testing

ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Apitope Technology (Bristol) Ltd. 43
Post-approval studies (Phase 4)WithdrawnNCT00101959
What this trial is testing

Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
EMD Serono
Not applicableStudy completedNCT01020370
What this trial is testing

Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

Who this might be right for
Multiple Sclerosis
Wayne State University
Not applicableStudy completedNCT03284970
What this trial is testing

Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 34
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Not applicableWithdrawnNCT05172466
What this trial is testing

Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Icahn School of Medicine at Mount Sinai
Not applicableStudy completedNCT00461396
What this trial is testing

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Bayer 104
Large-scale testing (Phase 3)Study completedNCT01497262
What this trial is testing

Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 162
Testing effectiveness (Phase 2)Study completedNCT00616187
What this trial is testing

Atorvastatin in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Charite University, Berlin, Germany 41
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation